New Tau PET Tracer Offers Early Alzheimer’s Detection with Precision
A new tau PET radiotracer, 18F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer’s disease in its earliest stages.
Category: Nuclear Medicine
Nuclear Medicine
Latest
Nuclear Medicine
Latest
PSMA PET/CT Waives the Need for Pre-Imaging Biopsy in Elderly Patients
New research highlights that PSMA PET/CT imaging can potentially diagnose advanced prostate cancer and guide treatment decisions without the need for biopsies in elderly patients, offering accurate staging data and potentially reducing complications associated with biopsies.
Nuclear Medicine
Latest
Personalized Dosing in Prostate Cancer Treatment Improves Patient Outcomes
By monitoring early-response biomarkers in men undergoing 177Lu-PSMA prostate cancer treatment, physicians can personalize dosing intervals, significantly improving patient outcomes.
Advances in PSMA PET-Guided Radiotherapy for Prostate Cancer
Physicians and scientists from University of California, Los Angeles will discuss research and clinical trial results on combination therapies for breast cancer, a new treatment for recurrent glioma, and advances in PSMA PET guided radiotherapy for prostate cancer at the American Society of Clinical Oncology’s annual meeting.
Read More
Nuclear Imaging Coalition Hails Senate’s FIND Act of 2023
MITA, CORAR, and SNMMI are commending Senators Blackburn and Baldwin for introducing the FIND Act (SB 1544), which aims to address reimbursement methodology and expand patient access to innovative diagnostic radiopharmaceutical drugs in nuclear medicine procedures.
Read More
Amino Acid PET Effective in Detecting Recurrent Brain Metastases
A newly published meta-analysis indicates that amino acid PET can accurately differentiate recurrent or progressive brain metastases from treatment-related changes.
Read More
Recurrent Brain Trauma May Increase Alzheimer’s Risk
New research finds that the brains of otherwise healthy military personnel who are exposed to explosions show an abnormal brain accumulation of amyloid-beta protein—a protein that plays a role in the development of Alzheimer’s disease.
Read More
Rapid Onsite FFR-CT Algorithm Helps Facilitates Clinical Adoption
A new deep-learning-based fractional flow reserve (FFR)-CT algorithm has been developed that shows excellent diagnostic performance for hemodynamically significant stenosis and provides a rapid and accurate onsite approach to address the challenges encountered in the clinical adoption of prior FFR-CT implementations.
Read More